Systems and methods for managing the power consumption of an oxygen concentrator are disclosed. An oxygen concentration system may comprise a compression system, a canister system, one or more processors, and at least one of a pressure sensor or a movement sensor. The one or more processors may be configured to transition the oxygen concentration system to at least one of a prescribed mode of operation or a standby mode of operation. The timing of the transition may be based on at least one of a number of breaths detected from the pressure signals generated by the pressure sensor or an estimated energy content of the movement signal generated by the movement sensor. A predetermined volume or concentration of oxygen enriched air may be supplied to a user during the prescribed mode of operation. A reduced power may be provided to the compression system during the standby mode of operation.

Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.

The invention relates to a ventilator comprising a gas source, at least one gas path and a patient conduit and at least two valves, each of the valves having at least indirectly a port for the surrounding air and each of the valves being at least temporarily connected to the gas source and/or the patient conduit so as to conduct gas.

A ventilation system that includes a pressure source, a pneumatic path configured to receive gas from the pressure source and comprising a first pneumatic component coupled to a second pneumatic component. The first pneumatic component includes a first electrical conductor including a first electrical component having a first electrical characteristic. The second pneumatic component comprises a second electrical conductor including a second electrical component having a second electrical characteristic. The first electrical conductor is electrically connected with the second electrical conductor in an electric path. The system performs operations including determining a continuity of the electrical path; displaying a notification regarding the continuity of the electrical path; detecting the unique electrical characteristic of the electric path; and determining a pneumatic characteristic of the pneumatic path.

Described is a method of stimulating airways of a mammal comprising: cyclically occluding a nasal air stream at a frequency rate between 50 Hz to 650 Hz. Also described is an apparatus for stimulating airways of a mammal, comprising: a fluid connection to each of a first and second naris of the mammal; and an occluding device configured to cyclically occlude a nasal air stream within each fluid connection at a frequency rate between 100 Hz to 650 Hz.

The invention relates to a respiratory-aid apparatus (1) capable of supplying a stream of gas to a patient (P), comprising a gas-transport pipe (2) for transporting a stream of gas, such as air; measurement means (6) designed to measure at least one parameter representing the stream of gas and to supply at least one signal corresponding to said at least one parameter representing said stream of gas, for example the gas flow rate or pressure; signal-processing means (8) designed to process said at least one signal from the measurement means (6) and to deduce therefrom at least one piece of information (I1, I2, I3) characterising a cardiac massage performed on a patient; and display means (7) designed to display said at least one piece of information (I1, I2, I3) characterising a cardiac massage from the signal-processing means (8). The signal-processing means (8) are preferably capable of determining information representing the work (W.sub.V, W.sub.T) provided by the massage or pressure and/or flow rate amplitudes resulting from the massage. The invention also relates to a monitoring method capable of being implemented by such a respiratory-aid apparatus (1).

Described herein are improved assisted ventilation interfaces along with methods and uses thereof. The interfaces comprises a hood embodiment with altered design aspects to decrease or even avoid the risk of leakage and potential viral transmittance along with providing other benefits. In one aspect, the patient interface comprises a hood with a free-breathing valve and an integral viral filter. The free-breathing valve and viral filter may be separate to or integral to the exhaust port. In a further embodiment multiple branches may be used from the exhaust port with multiple viral filters. In a further embodiment, an internal pressure gauge may be used. In a further embodiment dual air sources may be used.

Systems and methods are provided for aerosolizing and delivering therapeutic substances in an electronic aerosol delivery device with airflow regulation. Calibrated airflow resistance settings enable adjustment and control of flow velocity and or flow volume of air, aerosolized air, and or entrained aerosol particles, through the device, for optimal aerosol delivery among diverse conditions and applications.

Devices for delivering a controlled concentration of an agent are provided. The device includes a reservoir for the agent and a flow control portion operably connected to the reservoir. The device also includes a valve for releasing the agent from the flow control portion and a pump for flowing air to mix with the agent released by the valve and for flowing the agent and air mixture out of the device. Methods of delivering a vaporized agent to a subject are also provided. The methods include storing a liquid agent in a reservoir of a device and flowing the agent into a flow control chamber to change the agent to a gas. The methods also include mixing the agent in gas form with air and flowing the agent and air mixture out of the device to be delivered to a subject.

A method for controlling mechanical lung ventilation is described. The method may include intermittently switching the airway pressure of the patient from a substantially constant high baseline pressure level to a substantially constant low baseline pressure and vice-versa such that the patient is able to breathe spontaneously in both high and low baseline pressure levels; detecting an inspiration effort by the patient inside a trigger time window that immediately precedes a switching event of the intermittently switching the airway pressure; maintaining a baseline pressure at the level in which the inspiration effort was detected so that the patient can complete the inspiration-exhalation cycle; and switching the baseline pressure level after a delay time.